Advisor Group’s Collegium Pharmaceutical COLL Stock Holding History

Advisor Group’s Portfolio COLL Stock Details COLL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$12K	Buy	561 +463	+472%	+$7.72K	﹤0.01%	4234
2019 Q3	$1K	Hold	98	–	–	﹤0.01%	5088
2019 Q2	$1K	Buy	+98	New	+$1.31K	﹤0.01%	5081
2019 Q1	–	Sell	-3,400	Closed	-$58K	–	5225
2018 Q4	$58K	Sell	3,400 -402	-11%	-$6.88K	﹤0.01%	3075
2018 Q3	$56K	Buy	3,802 +3,402	+851%	+$60.3K	﹤0.01%	3193
2018 Q2	$10K	Buy	+400	New	+$9.84K	﹤0.01%	4064
2018 Q1	–	Sell	-10	Closed	–	–	4962
2017 Q4	$0	Buy	+10	New	+$143	﹤0.01%	4974

Other funds holding COLL

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return

Advisor Group's COLL Position: Q4 2019 in Review

Advisor Group increased its Collegium Pharmaceutical (COLL) stake by 472% in Q4 2019, buying an estimated $7.72K and bringing the position to 561 shares worth $12K. The position accounts for ﹤0.01% of the portfolio, ranked #4234.

Advisor Group first reported a position in COLL in Q4 2017 and has held it in 7 quarters since. The position peaked at $58K in Q4 2018. 138 funds tracked by Wall St. Rank hold COLL as of Q4 2019.

Advisor Group held 561 shares of Collegium Pharmaceutical worth $12K as of Q4 2019.
Advisor Group bought 463 Collegium Pharmaceutical shares in Q4 2019, an estimated $7.72K.
Collegium Pharmaceutical made up ﹤0.01% of Advisor Group's portfolio in Q4 2019, its #4234 holding.
Advisor Group first reported a position in Collegium Pharmaceutical in Q4 2017 and has held it in 7 quarters since.
Advisor Group's Collegium Pharmaceutical position peaked at $58K in Q4 2018.
138 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.